Mode
Text Size
Log in / Sign up

Thromboembolism

Part of Embolism and Thrombosis

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Thromboembolism

30 trials tracked for Thromboembolism: 15 in phase 3 or 4 and 3 with published results. The most-cited published study has 790 citations.

30Trials tracked
15Phase 3 & 4
0Recruiting
3With published results
Phase distribution
Phase 4 2 Phase 3 13 Phase 2 6 Other / NA 9
  1. Phase 3 Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism) Completed · 790 cited
  2. Phase 3 A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT) Completed · 311 cited
  3. Phase 4 ECMO Hemostatic Transfusions in Children Completed · 4 cited
  4. Phase 4 Self-management of Low Molecular Weight Heparin Therapy Completed
  5. Phase 3 Hip Fracture Study of GSK576428 (Fondaparinux Sodium) Completed
  6. Phase 3 Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism Completed
Show 24 more trials
  1. Phase 3 Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease Completed
  2. Phase 3 Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study). Completed
  3. Phase 3 Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE) Completed
  4. Phase 3 Secondary Prevention of Venous Thrombo Embolism (VTE). Completed
  5. Phase 3 Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee Replacement Completed
  6. Phase 3 Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin Completed
  7. Phase 3 Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery Completed
  8. Phase 3 Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement Completed
  9. Phase 3 RE-MODEL Dabigatran Etexilate 150mg or 220mg Once Daily (o.d.) Versus (v.s.) Enoxaparin 40mg o.d. for Prevention of Thrombosis After Knee Surgery Completed
  10. Phase 2 Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer Completed
  11. Phase 2 Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates Completed
  12. Phase 2 A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty Completed
  13. Phase 2 A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation Completed
  14. Phase 2 Low Molecular Weight Heparin or no Treatment Following Cesarean Delivery Completed
  15. Phase 2 Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT) Completed
  16. N/A A Study to Compare Health Care Costs Between Apixaban and Low Molecular Weight Heparin in Patients With Venous Thromboembolism and Cancer Completed
  17. N/A PraxbindTM India PMS Program Completed
  18. N/A Amplatzer™Amulet™ Post-Market Study (Amulet™PMS) Completed
  19. N/A Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism Completed
  20. N/A Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement Surgery Completed
  21. N/A Pradaxa (Dabigatran Etexilate 220 mg/q.d. in the General Population After Hip or Knee Replacement Surgery Completed
  22. N/A Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology Completed
  23. N/A Strategies for Anticoagulation During Venovenous ECMO Completed
  24. N/A AMPLATZER™ LAA Occluder Post Approval Study (PAS) Completed

Showing the 30 most-cited and recently-updated of 30 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Embolism and Thrombosis

Related studies from across the Embolism and Thrombosis family.

AI-guided ultrasound achieves 92.86% sensitivity for DVT triage, avoids 35.32% of standard scans
Radiology & Imaging RCT
AI-guided ultrasound achieves 92.86% sensitivity for DVT triage, avoids 35.32% of standard scans AI guidance helps doctors find blood clots in leg veins
In a multicenter nonrandomized study of 594 patients, an AI guidance system for proximal lower extremity compression ultrasounds achieved di…
A new AI system helps doctors quickly identify deep vein thrombosis and may reduce the need for standard ultrasound exams.
DOACs reduce thrombosis recurrence and major bleeding compared to warfarin in morbidly obese VTE patients
Diabetes & Endocrinology Meta-analysis
DOACs reduce thrombosis recurrence and major bleeding compared to warfarin in morbidly obese VTE patients DOACs Show Lower Risk of Blood Clots in Patients with Obesity
This meta-analysis of 44,672 patients found that DOACs are associated with lower risks of thrombosis recurrence (OR 0.74) and major bleeding…
New data suggests that direct acting oral anticoagulants may be more effective than warfarin for managing blood clots in patients with morbi…
Evaluating Enoxaparin Dosing Strategies for Venous Thromboembolism Prophylaxis in Bariatric Surgery Patients
Diabetes & Endocrinology Meta-analysis
Evaluating Enoxaparin Dosing Strategies for Venous Thromboembolism Prophylaxis in Bariatric Surgery Patients Higher enoxaparin doses do not change outcomes for bariatric surgery
A meta-analysis of 1,276 patients indicates that while 60 mg enoxaparin achieves higher anti-factor Xa levels, clinical outcomes remain simi…
A review of 1,276 patients shows that higher doses of the blood thinner enoxaparin do not improve safety or results for those undergoing wei…
Direct oral anticoagulants reduce thrombotic events and major bleeding in cirrhosis with atrial fibrillation or venous thromboembolism
Cardiology Meta-analysis
Direct oral anticoagulants reduce thrombotic events and major bleeding in cirrhosis with atrial fibrillation or venous thromboembolism Direct oral anticoagulants show promise for patients with liver cirrhosis
A meta-analysis of predominantly observational studies compared direct oral anticoagulants with traditional anticoagulants in patients with …
New analysis suggests direct oral anticoagulants may reduce blood clots and major bleeding risks for patients with liver cirrhosis and heart…
LMWH remains useful when oral anticoagulants are difficult to use safely in venous thromboembolism patients
Drug Pipeline Sys. Review
LMWH remains useful when oral anticoagulants are difficult to use safely in venous thromboembolism patients Low-molecular-weight heparin remains useful when oral anticoagulants are difficult to use safely
This narrative review examines low-molecular-weight heparin dosing, anti-factor Xa monitoring, treatment interruption, and switching strateg…
A review suggests low-molecular-weight heparin stays useful when oral anticoagulants are difficult to use safely for patients with venous th…
Pre-infection vaccination linked to lower cardiovascular and cerebrovascular event risks in SARS-CoV-2 infected individuals
Infectious Disease Sys. Review
Pre-infection vaccination linked to lower cardiovascular and cerebrovascular event risks in SARS-CoV-2 infected individuals Vaccination Before Infection Cuts Heart and Stroke Risks in COVID Patients
This systematic review and meta-analysis examined the association between pre-infection COVID-19 vaccination and cardiovascular outcomes in …
Pre-infection COVID-19 vaccination significantly lowers risks of heart attacks, strokes, and other cardiovascular events in infected individ…
Postoperative VTE prediction models show substantial heterogeneity and high bias risk in lung cancer surgery patients undergoing systematic review analysis
Oncology Meta-analysis
Postoperative VTE prediction models show substantial heterogeneity and high bias risk in lung cancer surgery patients undergoing systematic review analysis Existing lung cancer VTE prediction models show mixed results in surgery patients
A systematic review of twenty prediction models for venous thromboembolism in lung cancer surgery patients revealed substantial heterogeneit…
A review of twenty studies found that current tools for predicting blood clots in lung cancer surgery patients vary widely in accuracy and c…
Network meta-analysis compares DOACs and VKAs for intracranial hemorrhage risk
Cardiology Meta-analysis
Network meta-analysis compares DOACs and VKAs for intracranial hemorrhage risk Dabigatran may be safest for brain bleeding risk
This network meta-analysis of 127,267 patients with venous thromboembolism or atrial fibrillation found that all DOACs had lower risk of int…
All blood thinners beat warfarin for brain bleed risk, but dabigatran may be the safest choice.
Systematic review and meta-analysis links D-dimer and ultrasound findings to recurrent venous thromboembolism risk
Radiology & Imaging Meta-analysis
Systematic review and meta-analysis links D-dimer and ultrasound findings to recurrent venous thromboembolism risk Doctors find high D-dimer levels and ultrasound results predict higher risk of blood clot return
This systematic review and meta-analysis of 48 articles evaluates the association between residual vein thrombosis and positive post-treatme…
A review of many studies shows that leftover blood clots and high D-dimer levels after treatment raise the chance of venous thromboembolism …
Subprophylactic anti-Xa levels linked to higher venous thromboembolism risk in critically ill adults receiving low-molecular-weight heparin
Emergency Medicine Meta-analysis
Subprophylactic anti-Xa levels linked to higher venous thromboembolism risk in critically ill adults receiving low-molecular-weight heparin Low blood clot prevention drug levels linked to higher risk in sick adults
A systematic review and meta-analysis of 7,124 critically ill adults reveals that 47% failed to achieve target anti-Xa levels. Subprophylact…
A large review found that nearly half of critically ill adults did not reach safe drug levels. Those with lower levels faced a much higher c…
Meta-analysis identifies prognostic factors for recurrent VTE and bleeding in 96 753 adult cancer patients
Oncology Meta-analysis
Meta-analysis identifies prognostic factors for recurrent VTE and bleeding in 96 753 adult cancer patients Certain cancer types and health factors raise risk of blood clots or bleeding in adults with cancer and VTE
This meta-analysis evaluated prognostic factors for recurrent venous thromboembolism (VTE) or anticoagulant-related bleeding in 96 753 adult…
A large review found that specific cancers and health factors significantly increase the risk of recurrent blood clots or bleeding in adults…
Systematic review and meta-analysis finds high VTE incidence in stroke patients and moderate model performance
Cardiology Meta-analysis
Systematic review and meta-analysis finds high VTE incidence in stroke patients and moderate model performance Doctors Rethink How to Spot Blood Clots in Stroke Patients
This systematic review and meta-analysis of seven prediction models found a pooled VTE incidence of 20.8% in stroke patients.
It starts with a small ache in the leg. A little swelling.